187 related articles for article (PubMed ID: 30498495)
1. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.
Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML
Front Immunol; 2018; 9():2646. PubMed ID: 30498495
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.
Zdravkovic N; Shahin A; Arsenijevic N; Lukic ML; Mensah-Brown EP
Mol Immunol; 2009 Nov; 47(1):28-36. PubMed ID: 19356801
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
Müller A; Schott-Ohly P; Dohle C; Gleichmann H
Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
[TBL] [Abstract][Full Text] [Related]
4. Recombinant
Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
Herold KC; Vezys V; Sun Q; Viktora D; Seung E; Reiner S; Brown DR
J Immunol; 1996 May; 156(9):3521-7. PubMed ID: 8617981
[TBL] [Abstract][Full Text] [Related]
6. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets.
Montane J; Bischoff L; Soukhatcheva G; Dai DL; Hardenberg G; Levings MK; Orban PC; Kieffer TJ; Tan R; Verchere CB
J Clin Invest; 2011 Aug; 121(8):3024-8. PubMed ID: 21737880
[TBL] [Abstract][Full Text] [Related]
7. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
Flores RR; Zhou L; Robbins PD
Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
[TBL] [Abstract][Full Text] [Related]
8. Dual genetic absence of STAT6 and IL-10 does not abrogate anti-hyperglycemic effects of Schistosoma mansoni in streptozotocin-treated diabetic mice.
Osada Y; Fujiyama T; Kamimura N; Kaji T; Nakae S; Sudo K; Ishiwata K; Kanazawa T
Exp Parasitol; 2017 Jun; 177():1-12. PubMed ID: 28363777
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 prevents the development of autoimmune diabetes in NOD mice.
Lu J; Liang Y; Zhao J; Meng H; Zhang X
Int Immunopharmacol; 2019 May; 70():9-15. PubMed ID: 30780005
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
[TBL] [Abstract][Full Text] [Related]
11. Prevention of spontaneous and experimentally induced diabetes in mice with zinc sulfate-enriched drinking water is associated with activation and reduction of NF-kappa B and AP-1 in islets, respectively.
Schott-Ohly P; Lgssiar A; Partke HJ; Hassan M; Friesen N; Gleichmann H
Exp Biol Med (Maywood); 2004 Dec; 229(11):1177-85. PubMed ID: 15564445
[TBL] [Abstract][Full Text] [Related]
12. Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes.
Gerling IC; Friedman H; Greiner DL; Shultz LD; Leiter EH
Diabetes; 1994 Mar; 43(3):433-40. PubMed ID: 8314017
[TBL] [Abstract][Full Text] [Related]
13. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.
Kerkvliet NI; Steppan LB; Vorachek W; Oda S; Farrer D; Wong CP; Pham D; Mourich DV
Immunotherapy; 2009 Jul; 1(4):539-47. PubMed ID: 20174617
[TBL] [Abstract][Full Text] [Related]
14. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
Wang Z; Gleichmann H
Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
[TBL] [Abstract][Full Text] [Related]
15. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
17. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
[TBL] [Abstract][Full Text] [Related]
18. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
[TBL] [Abstract][Full Text] [Related]
19. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
20. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
